APP and Alzheimer disease: Neuron CTSS overexpression aggravates brain inflammatory milieu and increases neuron–microglia “crosstalk.” Furthermore, utilizing selective CTSS inhibitor, LY3000328, significantly rescues AD‐related phenotypes of APP/PS1 mice.